Source: StreetInsider

Press Release: Torque : Torque Presents New Preclinical Data for Three Deep-Primed Cellular Immunotherapy Programs, Including Newly Unveiled Deep TLR, at SITC 2019 Meeting

Read full article »
Torque's Competitors | Torque's News | Torque's Financials
Stay up-to-date with the latest news on Torque Therapeutics, Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
John G. Cox's photo - CEO of Torque Therapeutics, Inc.

CEO

John G. Cox

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Torque Therapeutics, Inc.